Literature DB >> 3493263

Reassessment of faecal alpha-1-antitrypsin excretion for use as screening test for intestinal protein loss.

E M Quigley, I N Ross, M R Haeney, I B Holbrook, M N Marsh.   

Abstract

Faecal alpha-1-antitrypsin and 51Cr-albumin losses in 42 patients with either gastrointestinal or hepatic disease were compared. The reference range was derived from measurements in 20 controls without gastrointestinal disease. Alpha-1-antitrypsin excretion was increased in patients with excessive 51Cr-albumin loss, and correlations were found between alpha-1-antitrypsin clearance and 51Cr-albumin excretion. Because of the considerable overlap of faecal alpha-1-antitrypsin excretion between controls and patients, sensitivity and specificity of the test were only 58% and 80%, respectively. This poor reliability could not be explained by sampling error or temporal variations in alpha-1-antitrypsin excretion. These results show that although faecal alpha-1-antitrypsin excretion correlates with 51Cr-albumin excretion when whole groups of patients are studied, its poor sensitivity makes it an unreliable measure of enteric protein loss.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3493263      PMCID: PMC1140829          DOI: 10.1136/jcp.40.1.61

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  11 in total

1.  Simple method for diagnosing protein-losing enteropathies.

Authors:  J R Crossley; R B Elliott
Journal:  Br Med J       Date:  1977-02-12

Review 2.  The role of the gastrointestinal tract in plasma protein metabolism. Studies with 51Cr-albumin.

Authors:  T A Waldmann; R D Wochner; W Strober
Journal:  Am J Med       Date:  1969-02       Impact factor: 4.965

3.  Abnormal infants of diabetic mothers.

Authors:  J M Steel; F Johnstone; L J Duncan
Journal:  Lancet       Date:  1980-04-05       Impact factor: 79.321

4.  Characterization and evaluation of immunochemical methods for the measurement of fecal alpha 1-antitrypsin.

Authors:  G J Buffone; R J Shulman
Journal:  Am J Clin Pathol       Date:  1985-03       Impact factor: 2.493

5.  Exudative enteropathy. I. A comparative study of Cr51-Cl and I-131-PVP.

Authors:  M E RUBINI; T W SHEEHY
Journal:  J Lab Clin Med       Date:  1961-12

6.  Use of 125-I- and 51-Cr-labeled albumin for the measurement of gastrointestinal and total albumin catabolism.

Authors:  R M Kerr; J J Du Bois; P R Holt
Journal:  J Clin Invest       Date:  1967-12       Impact factor: 14.808

7.  Alpha-1-antitrypsin in duodenal fluid and gallbladder bile.

Authors:  T O Kyaw-Myint; A M Howell; G M Murphy; C M Anderson
Journal:  Clin Chim Acta       Date:  1975-02-22       Impact factor: 3.786

8.  Diagnosis of protein-losing enteropathy by gastrointestinal clearance of alpha1-antitrypsin.

Authors:  J J Bernier; C Florent; C Desmazures; C Aymes; C L'Hirondel
Journal:  Lancet       Date:  1978-10-07       Impact factor: 79.321

9.  [Evaluation of protein-losing enteropathy in the cirrhotic patient by assessing the intestinal clearance of alpha 1 antitrypsin (author's transl)].

Authors:  J F Bretagne; P Lemee; E Esvant; J Gastard
Journal:  Sem Hop       Date:  1982-03-11

10.  Comparison of gastrointestinal loss of alpha-1-antitrypsin and chromium-51-albumin in Ménétrier's disease and the influence of ranitidine.

Authors:  W H Reinhart; K Weigand; M Kappeler; H Roesler; F Halter
Journal:  Digestion       Date:  1983       Impact factor: 3.216

View more
  6 in total

1.  Portal vein thrombosis and pancreatic failure.

Authors:  N A Afzal; M J Brueton; J M Fell; A Baker
Journal:  Int J Pancreatol       Date:  2001

2.  Heparan sulfate and syndecan-1 are essential in maintaining murine and human intestinal epithelial barrier function.

Authors:  Lars Bode; Camilla Salvestrini; Pyong Woo Park; Jin-Ping Li; Jeffrey D Esko; Yu Yamaguchi; Simon Murch; Hudson H Freeze
Journal:  J Clin Invest       Date:  2008-01       Impact factor: 14.808

3.  Fecal excretion of alpha 1-antitrypsin in patients with Crohn's disease. A comparison of nephelometry and radial immunodiffusion.

Authors:  A López; J Hinojosa; A Miralles; J Primo; J D Bermúdez
Journal:  Dig Dis Sci       Date:  1994-03       Impact factor: 3.199

4.  A case of severe protein-losing enteropathy as a late complication of pelvic irradiation.

Authors:  Wee Sik Sohn; Duck Ryung Kim; Jong Sin Lee; Gi Jeong Cheon; Byung-Hee Lee; Seung-Sook Lee; Sook-Hyang Jeong
Journal:  Korean J Intern Med       Date:  2004-12       Impact factor: 2.884

Review 5.  Human serum albumin homeostasis: a new look at the roles of synthesis, catabolism, renal and gastrointestinal excretion, and the clinical value of serum albumin measurements.

Authors:  David G Levitt; Michael D Levitt
Journal:  Int J Gen Med       Date:  2016-07-15

Review 6.  Protein losing enteropathy: comprehensive review of the mechanistic association with clinical and subclinical disease states.

Authors:  David G Levitt; Michael D Levitt
Journal:  Clin Exp Gastroenterol       Date:  2017-07-17
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.